TERT promotor mutation status was available in 67/95 patients (70.5%), revealing TERT promotor mutations in six of 67 patients (9.0%) and leading to a re-classification as anaplastic meningioma WHO grade 3 in three cases. This evidence concerns the gene TERT and anaplastic meningioma.